Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.
Identifieur interne : 000419 ( PubMed/Curation ); précédent : 000418; suivant : 000420Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.
Auteurs : Masakazu Kono [Japon] ; Koichiro Tatsumi ; Alberto M. Imai ; Kengo Saito ; Takayuki Kuriyama ; Hiroshi ShirasawaSource :
- Antiviral research [ 0166-3542 ] ; 2008.
Descripteurs français
- KwdFr :
- Antiviraux (pharmacologie), Cellules épithéliales (virologie), Chloroquine (pharmacologie), Coronavirus humain 229E (), Effet cytopathogène viral (), Extracellular Signal-Regulated MAP Kinases (antagonistes et inhibiteurs), Humains, Imidazoles (pharmacologie), Lignée cellulaire, Poumon (cytologie), Poumon (virologie), Pyridines (pharmacologie), RT-PCR, Réplication virale (), p38 Mitogen-Activated Protein Kinases (antagonistes et inhibiteurs).
- MESH :
- antagonistes et inhibiteurs : Extracellular Signal-Regulated MAP Kinases, p38 Mitogen-Activated Protein Kinases.
- cytologie : Poumon.
- pharmacologie : Antiviraux, Chloroquine, Imidazoles, Pyridines.
- virologie : Cellules épithéliales, Poumon.
- Coronavirus humain 229E, Effet cytopathogène viral, Humains, Lignée cellulaire, RT-PCR, Réplication virale.
English descriptors
- KwdEn :
- Antiviral Agents (pharmacology), Cell Line, Chloroquine (pharmacology), Coronavirus 229E, Human (drug effects), Cytopathogenic Effect, Viral (drug effects), Epithelial Cells (virology), Extracellular Signal-Regulated MAP Kinases (antagonists & inhibitors), Humans, Imidazoles (pharmacology), Lung (cytology), Lung (virology), Pyridines (pharmacology), Reverse Transcriptase Polymerase Chain Reaction, Virus Replication (drug effects), p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors).
- MESH :
- chemical , antagonists & inhibitors : Extracellular Signal-Regulated MAP Kinases, p38 Mitogen-Activated Protein Kinases.
- chemical , pharmacology : Antiviral Agents, Chloroquine, Imidazoles, Pyridines.
- cytology : Lung.
- drug effects : Coronavirus 229E, Human, Cytopathogenic Effect, Viral, Virus Replication.
- virology : Epithelial Cells, Lung.
- Cell Line, Humans, Reverse Transcriptase Polymerase Chain Reaction.
Abstract
The antiviral effects of chloroquine (CQ) on human coronavirus 229E (HCoV-229E) infection of human fetal lung cell line, L132 are reported. CQ significantly decreased the viral replication at concentrations lower than in clinical usage. We demonstrated that CQ affects the activation of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK). Furthermore, p38 MAPK inhibitor, SB203580, inhibits CPE induced by HCoV-229E infection and viral replication. Our findings suggest that CQ affects the activation of MAPKs, involved in the replication of HCoV-229E.
DOI: 10.1016/j.antiviral.2007.10.011
PubMed: 18055026
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000419
Links to Exploration step
pubmed:18055026Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.</title>
<author><name sortKey="Kono, Masakazu" sort="Kono, Masakazu" uniqKey="Kono M" first="Masakazu" last="Kono">Masakazu Kono</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular Virology, Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Molecular Virology, Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tatsumi, Koichiro" sort="Tatsumi, Koichiro" uniqKey="Tatsumi K" first="Koichiro" last="Tatsumi">Koichiro Tatsumi</name>
</author>
<author><name sortKey="Imai, Alberto M" sort="Imai, Alberto M" uniqKey="Imai A" first="Alberto M" last="Imai">Alberto M. Imai</name>
</author>
<author><name sortKey="Saito, Kengo" sort="Saito, Kengo" uniqKey="Saito K" first="Kengo" last="Saito">Kengo Saito</name>
</author>
<author><name sortKey="Kuriyama, Takayuki" sort="Kuriyama, Takayuki" uniqKey="Kuriyama T" first="Takayuki" last="Kuriyama">Takayuki Kuriyama</name>
</author>
<author><name sortKey="Shirasawa, Hiroshi" sort="Shirasawa, Hiroshi" uniqKey="Shirasawa H" first="Hiroshi" last="Shirasawa">Hiroshi Shirasawa</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:18055026</idno>
<idno type="pmid">18055026</idno>
<idno type="doi">10.1016/j.antiviral.2007.10.011</idno>
<idno type="wicri:Area/PubMed/Corpus">000419</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000419</idno>
<idno type="wicri:Area/PubMed/Curation">000419</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000419</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.</title>
<author><name sortKey="Kono, Masakazu" sort="Kono, Masakazu" uniqKey="Kono M" first="Masakazu" last="Kono">Masakazu Kono</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Molecular Virology, Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670, Japan.</nlm:affiliation>
<country xml:lang="fr">Japon</country>
<wicri:regionArea>Department of Molecular Virology, Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Tatsumi, Koichiro" sort="Tatsumi, Koichiro" uniqKey="Tatsumi K" first="Koichiro" last="Tatsumi">Koichiro Tatsumi</name>
</author>
<author><name sortKey="Imai, Alberto M" sort="Imai, Alberto M" uniqKey="Imai A" first="Alberto M" last="Imai">Alberto M. Imai</name>
</author>
<author><name sortKey="Saito, Kengo" sort="Saito, Kengo" uniqKey="Saito K" first="Kengo" last="Saito">Kengo Saito</name>
</author>
<author><name sortKey="Kuriyama, Takayuki" sort="Kuriyama, Takayuki" uniqKey="Kuriyama T" first="Takayuki" last="Kuriyama">Takayuki Kuriyama</name>
</author>
<author><name sortKey="Shirasawa, Hiroshi" sort="Shirasawa, Hiroshi" uniqKey="Shirasawa H" first="Hiroshi" last="Shirasawa">Hiroshi Shirasawa</name>
</author>
</analytic>
<series><title level="j">Antiviral research</title>
<idno type="ISSN">0166-3542</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiviral Agents (pharmacology)</term>
<term>Cell Line</term>
<term>Chloroquine (pharmacology)</term>
<term>Coronavirus 229E, Human (drug effects)</term>
<term>Cytopathogenic Effect, Viral (drug effects)</term>
<term>Epithelial Cells (virology)</term>
<term>Extracellular Signal-Regulated MAP Kinases (antagonists & inhibitors)</term>
<term>Humans</term>
<term>Imidazoles (pharmacology)</term>
<term>Lung (cytology)</term>
<term>Lung (virology)</term>
<term>Pyridines (pharmacology)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Virus Replication (drug effects)</term>
<term>p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antiviraux (pharmacologie)</term>
<term>Cellules épithéliales (virologie)</term>
<term>Chloroquine (pharmacologie)</term>
<term>Coronavirus humain 229E ()</term>
<term>Effet cytopathogène viral ()</term>
<term>Extracellular Signal-Regulated MAP Kinases (antagonistes et inhibiteurs)</term>
<term>Humains</term>
<term>Imidazoles (pharmacologie)</term>
<term>Lignée cellulaire</term>
<term>Poumon (cytologie)</term>
<term>Poumon (virologie)</term>
<term>Pyridines (pharmacologie)</term>
<term>RT-PCR</term>
<term>Réplication virale ()</term>
<term>p38 Mitogen-Activated Protein Kinases (antagonistes et inhibiteurs)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Extracellular Signal-Regulated MAP Kinases</term>
<term>p38 Mitogen-Activated Protein Kinases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Antiviral Agents</term>
<term>Chloroquine</term>
<term>Imidazoles</term>
<term>Pyridines</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Extracellular Signal-Regulated MAP Kinases</term>
<term>p38 Mitogen-Activated Protein Kinases</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr"><term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en"><term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Coronavirus 229E, Human</term>
<term>Cytopathogenic Effect, Viral</term>
<term>Virus Replication</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antiviraux</term>
<term>Chloroquine</term>
<term>Imidazoles</term>
<term>Pyridines</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Cellules épithéliales</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Epithelial Cells</term>
<term>Lung</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Cell Line</term>
<term>Humans</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Coronavirus humain 229E</term>
<term>Effet cytopathogène viral</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>RT-PCR</term>
<term>Réplication virale</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The antiviral effects of chloroquine (CQ) on human coronavirus 229E (HCoV-229E) infection of human fetal lung cell line, L132 are reported. CQ significantly decreased the viral replication at concentrations lower than in clinical usage. We demonstrated that CQ affects the activation of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK). Furthermore, p38 MAPK inhibitor, SB203580, inhibits CPE induced by HCoV-229E infection and viral replication. Our findings suggest that CQ affects the activation of MAPKs, involved in the replication of HCoV-229E.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">18055026</PMID>
<DateCompleted><Year>2008</Year>
<Month>04</Month>
<Day>10</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>11</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0166-3542</ISSN>
<JournalIssue CitedMedium="Print"><Volume>77</Volume>
<Issue>2</Issue>
<PubDate><Year>2008</Year>
<Month>Feb</Month>
</PubDate>
</JournalIssue>
<Title>Antiviral research</Title>
<ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
</Journal>
<ArticleTitle>Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK.</ArticleTitle>
<Pagination><MedlinePgn>150-2</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The antiviral effects of chloroquine (CQ) on human coronavirus 229E (HCoV-229E) infection of human fetal lung cell line, L132 are reported. CQ significantly decreased the viral replication at concentrations lower than in clinical usage. We demonstrated that CQ affects the activation of p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK). Furthermore, p38 MAPK inhibitor, SB203580, inhibits CPE induced by HCoV-229E infection and viral replication. Our findings suggest that CQ affects the activation of MAPKs, involved in the replication of HCoV-229E.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kono</LastName>
<ForeName>Masakazu</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Molecular Virology, Chiba University School of Medicine, 1-8-1 Inohana, Chiba 260-8670, Japan.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Tatsumi</LastName>
<ForeName>Koichiro</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Imai</LastName>
<ForeName>Alberto M</ForeName>
<Initials>AM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Saito</LastName>
<ForeName>Kengo</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Kuriyama</LastName>
<ForeName>Takayuki</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y"><LastName>Shirasawa</LastName>
<ForeName>Hiroshi</ForeName>
<Initials>H</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2007</Year>
<Month>11</Month>
<Day>20</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Netherlands</Country>
<MedlineTA>Antiviral Res</MedlineTA>
<NlmUniqueID>8109699</NlmUniqueID>
<ISSNLinking>0166-3542</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D007093">Imidazoles</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D011725">Pyridines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>886U3H6UFF</RegistryNumber>
<NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048049">Extracellular Signal-Regulated MAP Kinases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 2.7.11.24</RegistryNumber>
<NameOfSubstance UI="D048051">p38 Mitogen-Activated Protein Kinases</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>OU13V1EYWQ</RegistryNumber>
<NameOfSubstance UI="C093642">SB 203580</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D028941" MajorTopicYN="N">Coronavirus 229E, Human</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003588" MajorTopicYN="N">Cytopathogenic Effect, Viral</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004847" MajorTopicYN="N">Epithelial Cells</DescriptorName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D048049" MajorTopicYN="N">Extracellular Signal-Regulated MAP Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007093" MajorTopicYN="N">Imidazoles</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000166" MajorTopicYN="N">cytology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011725" MajorTopicYN="N">Pyridines</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D048051" MajorTopicYN="N">p38 Mitogen-Activated Protein Kinases</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2007</Year>
<Month>07</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2007</Year>
<Month>10</Month>
<Day>15</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2007</Year>
<Month>10</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2007</Year>
<Month>12</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>4</Month>
<Day>11</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2007</Year>
<Month>12</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">18055026</ArticleId>
<ArticleId IdType="pii">S0166-3542(07)00459-7</ArticleId>
<ArticleId IdType="doi">10.1016/j.antiviral.2007.10.011</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000419 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000419 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:18055026 |texte= Inhibition of human coronavirus 229E infection in human epithelial lung cells (L132) by chloroquine: involvement of p38 MAPK and ERK. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:18055026" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a ChloroquineV1
This area was generated with Dilib version V0.6.33. |